Anderman Jonathan (CIK 0002032625)

Latest company ownership

Role: Gen Counsel & Corporate Sec
Shares held
21,000
Last filed at
Apr 8, 2025
Confidence Score
51.9
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 7, 2025 Apr 8, 2025 Compass Therapeutics, Inc. Gen Counsel & Corporate Sec Buy 91.3 +20,000 2000.00% $30.8K